Authors:
Fulghesu, AM
Ciampelli, M
Belosi, C
Apa, R
Guido, M
Caruso, A
Mancuso, S
Lanzone, A
Citation: Am. Fulghesu et al., Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study, J ENDOC INV, 24(7), 2001, pp. 483-490
Authors:
Fulghesu, AM
Ciampelli, M
Belosi, C
Apa, R
Pavone, V
Lanzone, A
Citation: Am. Fulghesu et al., A new ultrasound criterion for the diagnosis of polycystic ovary syndrome:the ovarian stroma/total area ratio, FERT STERIL, 76(2), 2001, pp. 326-331
Authors:
De Leo, V
Fulghesu, AM
la Marca, A
Morgante, G
Pasqui, L
Talluri, B
Torricelli, M
Caruso, A
Citation: V. De Leo et al., Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism, GYNECOL END, 14(6), 2000, pp. 411-416
Authors:
Ciampelli, M
Fulghesu, AM
Cucinelli, F
Pavone, V
Ronsisvalle, E
Guido, M
Caruso, A
Lanzone, A
Citation: M. Ciampelli et al., Impact of insulin and body mass index on metabolic and endocrine variablesin polycystic ovary syndrome, METABOLISM, 48(2), 1999, pp. 167-172
Citation: M. Ciampelli et al., Comment on "Prevalence and predictors of risk for type 2 diabetes mellitusand impaired glucose tolerance in polycystic ovary syndrome", J CLIN END, 84(8), 1999, pp. 2974-2975
Authors:
Guido, M
Ciampelli, M
Fulghesu, AM
Pavone, V
Barini, A
De Marinis, L
Cento, R
Caruso, A
Lanzone, A
Citation: M. Guido et al., Influence of body mass on the hypothalamic-pituitary-adrenal-axis responseto naloxone in patients with polycystic ovary syndrome, FERT STERIL, 71(3), 1999, pp. 462-467
Authors:
Villa, P
Valle, D
Mancini, A
De Marinis, L
Pavone, V
Fulghesu, AM
Mancuso, S
Lanzone, A
Citation: P. Villa et al., Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism, FERT STERIL, 71(1), 1999, pp. 115-121